Medical Properties Trust insider awarded time‑vested and TSR‑based shares
Rhea-AI Filing Summary
Medical Properties Trust insider share grants and vesting details
SVP of Operations Rosa Handley was granted two non‑cash awards on 09/24/2025: 36,765 shares that vest quarterly through March 31, 2028 and 15,420 performance‑based shares tied to three‑year total shareholder return (TSR) hurdles through April 14, 2028. The performance shares pay out 100% at 20% TSR, 200% at 40% TSR and 300% at 60% TSR with linear interpolation for intermediate results; earned shares vest quarterly over one year or immediately upon final committee determination. Reported beneficial ownership after transactions is 400,743 shares (direct).
Positive
- Insider acquisition reported: Rosa Handley received 36,765 time‑vesting shares and 15,420 performance‑based shares on 09/24/2025
- Performance alignment: Performance shares are tied to explicit TSR hurdles (20%/40%/60%) with up to 300% payout and linear interpolation
- Clear vesting schedule: Time‑vested shares vest quarterly through March 31, 2028 and earned performance shares vest quarterly over the year following performance determination
Negative
- None.
Insights
TL;DR: Insider received time‑based and performance‑based equity grants aligning compensation with long‑term TSR.
The grant structure combines quarterly time‑vested shares and multi‑year TSR performance awards, which aligns executive incentives with shareholder returns without immediate cash outlay. The performance hurdles are explicit: 20%/40%/60% TSR tiers with up to 300% payout and interpolation, creating clear pay‑for‑performance targets. The awards will not dilute current holders immediately as they are subject to vesting and performance conditions, and the report shows the holder retains substantial direct ownership (400,743 shares) after the grant.
TL;DR: Grant terms reflect common governance practice: multi‑year performance metrics plus time‑based vesting to retain management.
The combination of TSR‑linked performance awards and quarterly vesting of earned shares is a standard retention and alignment mechanism. The disclosure clearly describes vesting schedule and measurement period, aiding investor assessment of incentive design. No information here indicates change in control, unusual acceleration, or other governance red flags; the filing documents standard Section 16 reporting of an insider award.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common stock, par value $0.001 | 36,765 | $0.00 | -- |
| Grant/Award | Common stock, par value $0.001 | 15,420 | $0.00 | -- |
Footnotes (1)
- Shares vest at the beginning of each calendar quarter ending March 31, 2028. The shares were granted under the Medical Properties Trust, Inc. ("the Company") Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified Company total shareholder return ("TSR") hurdles during the three-year period ending April 14, 2028 as follows: (i) if the Company's TSR reaches 20%, 100% of the shares will be earned; (ii) if the Company's TSR reaches 40%, 200% of the shares will be earned; and (iii) if the Company's TSR reaches 60%, 300% of the shares will be earned. The actual number of shares to be earned will be determined based on the trailing 20-trading day average, determined quarterly; provided, however, following the end of such three-year performance period, achievement of performance between specific TSR hurdles described above will be determined using straight line linear interpolation (continued on footnote 3). Earned shares will become vested in equal quarterly installments over one year following the date the shares are earned, provided that all unvested earned shares will vest in full on the date that the Compensation Committee makes the final determination regarding performance metrics following the end of the three-year performance period, subject to the grantee's continued employment through such date.
